FMTs demonstrates transient metabolic benefits in obesity management, with lean donor FMT inducing short-term (6-week) improvements in microbial butyrogenesis and insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.